| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single an Chronic Spontaneous Urticaria | Phase 1 | 2025-11-10 |
| Completed | Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects Complement Mediated Glomerular Diseases, Hemolytic Anemia | Phase 1 | 2025-07-08 |
| Completed | A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Health IgA Nephropathy, Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | 2025-06-30 |
| Recruiting | A Trial of HRS-5965 Capsule in Primary IgA Nephropathy Primary IgA Nephropathy | Phase 3 | 2025-06-04 |
| Completed | Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2025-01-07 |
| Completed | Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment Complement Mediated Primary or Secondary Glomerular Diseases | Phase 1 | 2024-11-26 |
| Completed | A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in H Hemolytic Anemia | Phase 1 | 2024-11-09 |
| Completed | A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2024-10-25 |
| Completed | A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male Volunteers Complement Mediated Primary or Secondary Glomerular Diseases | Phase 1 | 2024-09-03 |
| Completed | Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects Paroxysmal Nocturnal Hemoglobinuria，IgA Nephropathy | Phase 1 | 2024-07-17 |
| Active Not Recruiting | Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | 2024-02-06 |
| Active Not Recruiting | A Trial of HRS-5965 Tablets in Primary IgA Nephropathy Primary IgA Nephropathy | Phase 2 | 2023-12-19 |
| Completed | Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemogl Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | 2023-11-15 |
| Completed | A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Ar Chronic Hepatitis B | Phase 2 | 2023-07-28 |
| Completed | Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency Glomerulonephritis | Phase 1 | 2022-10-08 |
| Unknown | A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Seco Secondary Hyperparathyroidism | Phase 3 | 2022-02-01 |